NavonTech

NavonTechNavonTech
N

NavonTech

Developed GlycemiaCare, a noninvasive wearable for identifying nocturnal hypoglycemia in diabetics.

DR 52017Inactive3
Rate

About

NavonTech developed GlycemiaCare, a noninvasive wearable technology designed to identify nocturnal hypoglycemia. This condition, a drop in blood glucose levels, is a complication associated with insulin treatment for diabetes. The company aimed to provide a solution for diabetics experiencing these issues.
Frequently asked

What does NavonTech do?

NavonTech developed GlycemiaCare, a noninvasive wearable technology designed to identify nocturnal hypoglycemia. This condition, a drop in blood glucose levels, is a complication associated with insulin treatment for diabetes. The company aimed to provide a solution for diabetics experiencing these issues.

What is NavonTech's revenue?

StartupHub estimates NavonTech's annual revenue at $507K (range $306K to $1.0M, 65% confidence), based on comparable companies in the sector.

When was NavonTech founded?

NavonTech was founded in 2017.

What industry does NavonTech operate in?

NavonTech operates in Healthcare, Monitor, Diabetes, HealthTech, MedTech, Wearables.

How many employees does NavonTech have?

NavonTech has approximately 3 people on record.

What is NavonTech's current status?

NavonTech's current operating status is: Inactive.

HEADCOUNT
3
DOMAIN RATING
5
Comments

No comments yet. Be the first to share your take.